Boston Scientific today announced the appointment of Xavier Bertrand as president and SVP for the EMEA region.

That doesn't mean the loss of Marcus doesn't smart (pun intended) for Celtics fans, but it is hard to see the deal as ...

Intera’s portfolio consists of Intera 3000 Hepatic Artery Infusion Pump, which is used to administer chemotherapy in liver ...

Garrett Crochet caught the attention of several teams with his successful move from the bullpen to the rotation in 2024. The ...

Boston Scientific (BSX) ended the recent trading session at $90.53, demonstrating a -0.34% swing from the preceding day's closing price. This change lagged the S&P 500's 0.19% loss on the day.

From M&A and tariffs to new health leaders, here are the top issues for the medtech industry to watch when President-elect ...

Analysts from Bank of America predict a favorable environment for mergers and acquisitions in the medtech space in 2025.

The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken sandwiches and burritos to Silk Road Medical employees in California and ...

Two Boston-area biotechs are shedding staff and merging together to form a new genetic medicines company. | Chroma Medicines ...

PHG Koninklijke Philips N.V.

For the quarter that ended on Oct. 31, C3 AI reported an adjusted net loss per share of six cents, down from a loss of 16 ...

What's next for the stock? We take a look at earnings estimates for some clues. Boston Scientific's (NYSE:BSX) stock is up by a considerable 11% over the past three months. But the company's key ...